You can check out the annual or quarterly balance sheets of NewAmsterdam Pharma Company NV here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2022Q4

FY2022Q2

Total equity

Cash, cash equivalents and short-term investments

-14.25%633.85M

-21.32%636.11M

-23.73%636.24M

66.29%702.95M

71.62%739.16M

68.03%808.48M

145.03%834.19M

--422.73M

--430.71M

--481.15M

-27.21%340.45M

--467.73M

--93.79M

- Cash and cash equivalents

-24.78%424.15M

-38.86%457.61M

-36.51%490.00M

27.36%538.41M

30.92%563.86M

55.55%748.42M

126.68%771.74M

--422.73M

--430.71M

--481.15M

-27.21%340.45M

--467.73M

--93.79M

-Short-term investments

19.63%209.70M

197.21%178.50M

134.18%146.24M

--164.54M

--175.30M

--60.06M

--62.45M

----

Receivables

-72.94%5.34M

409.67%8.22M

8.67%23.15M

293.49%20.25M

265.33%19.75M

-60.97%1.61M

1032.64%21.30M

--5.15M

--5.41M

--4.13M

-9.13%1.88M

--2.07M

--121.18M

-Accounts and notes receivable

----

--120.54M

-Other receivables

-73.67%5.11M

455.83%8.02M

9.23%22.92M

1117.68%20.04M

809.28%19.40M

-63.81%1.44M

2298.17%20.98M

--1.65M

--2.13M

--3.98M

--875.00K

--0.00

----

Prepaid expenses

70.52%18.65M

71.64%12.38M

89.26%14.99M

-21.74%7.83M

18.40%10.94M

183.79%7.21M

77.53%7.92M

--10.00M

--9.24M

--2.54M

-45.48%4.46M

--8.18M

--12.44M

Other current assets

--1.36M

881.29%1.34M

--1.32M

--1.31M

----

---171.00K

----

Total current assets

-14.37%659.21M

-19.49%658.04M

-21.74%675.70M

67.25%732.33M

72.86%769.85M

67.54%817.30M

148.97%863.41M

--437.87M

--445.35M

--487.82M

-27.45%346.79M

--477.98M

--227.41M

Non-current assets

Net Fixed Assets

-20.48%493.00K

-34.10%400.00K

-15.60%568.00K

-21.41%569.00K

-21.32%620.00K

336.69%607.00K

566.34%673.00K

--724.00K

--788.00K

--139.00K

-34.42%101.00K

--154.00K

--183.43K

Goodwill and other intangible assets

-27.02%343.00K

-25.30%375.00K

-23.78%407.00K

-25.97%439.00K

-13.28%470.00K

3.29%502.00K

214.12%534.00K

--593.00K

--542.00K

--486.00K

-18.27%170.00K

--208.00K

----

Long-term debt

----

--763.09K

Long-term prepaid expenses

----

--2.58M

----

-100.00%0.00

----

--8.00K

--16.00K

-77.56%35.00K

--156.00K

----

Other non-current assets

--0.00

--2.58M

----

-100.00%0.00

----

--8.00K

--16.00K

-77.56%35.00K

--156.00K

----

Total non-current assets

-0.04%45.24M

6626.69%74.60M

7653.44%93.58M

4007.74%54.10M

3282.81%45.26M

73.01%1.11M

294.44%1.21M

--1.32M

--1.34M

--641.00K

-40.93%306.00K

--518.00K

--946.52K

Total assets

-13.58%704.45M

-10.48%732.64M

-11.03%769.28M

79.06%786.43M

82.48%815.11M

67.55%818.41M

149.10%864.62M

--439.19M

--446.69M

--488.46M

-27.46%347.10M

--478.50M

--228.35M

Liabilities

Current liabilities

-Other payables

----

--0.00

----

Accrued expenses

8.64%10.28M

-36.52%5.09M

13.33%15.42M

-4.56%10.10M

-7.20%9.46M

-19.55%8.02M

19.39%13.61M

--10.58M

--10.19M

--9.97M

86.33%11.40M

--6.12M

----

Short-term debt and lease liabilities

----

-9.09%60.00K

--66.00K

--63.94K

-Short-term lease liabilities

----

-9.09%60.00K

--66.00K

--63.94K

Deferred liabilities

--2.80M

31.58%3.99M

-33.64%3.99M

----

-100.00%0.00

-62.67%3.03M

-32.81%6.01M

--4.50M

--6.06M

--8.12M

-35.55%8.94M

--13.87M

--14.74M

Other current liabilities

--2.80M

31.58%3.99M

-33.64%3.99M

----

-100.00%0.00

-62.67%3.03M

-32.81%6.01M

--4.50M

--6.06M

--8.12M

-35.55%8.94M

--13.87M

--14.74M

Total current liabilities

99.86%72.97M

64.79%67.42M

-19.76%85.79M

41.25%58.27M

-19.41%36.51M

-31.50%40.91M

114.28%106.92M

--41.26M

--45.31M

--59.73M

38.38%49.90M

--36.06M

--27.15M

Non-current liabilities

Long-term debt and lease liabilities

-45.63%56.00K

-100.00%0.00

-67.33%66.00K

-68.05%85.00K

-68.60%103.00K

--137.00K

--202.00K

--266.00K

--328.00K

--0.00

-Long-term lease liabilities

-45.63%56.00K

-100.00%0.00

-67.33%66.00K

-68.05%85.00K

-68.60%103.00K

--137.00K

--202.00K

--266.00K

--328.00K

----

Deferred liabilities

----

-100.00%0.00

--0.00

--222.00K

--444.00K

-78.74%1.02M

--4.79M

--7.80M

Derivatives liabilities

----

-100.00%0.00

--18.81M

--13.39M

--16.49M

3.54%7.79M

--7.52M

----

Other non-current liabilities

--0.00

----

-100.00%0.00

--0.00

--222.00K

--444.00K

-78.74%1.02M

--4.79M

--7.80M

Total non-current liabilities

-45.63%56.00K

-100.00%0.00

-67.33%66.00K

-99.55%85.00K

-99.26%103.00K

-99.19%137.00K

-97.71%202.00K

--19.07M

--13.94M

--16.93M

-28.83%8.81M

--12.37M

--7.89M

Total liabilities

99.45%73.03M

64.24%67.42M

-19.85%85.85M

-3.27%58.36M

-38.20%36.62M

-46.45%41.05M

82.47%107.12M

--60.33M

--59.25M

--76.66M

21.21%58.70M

--48.43M

--35.04M

Shareholders' equity

Common equity

8.12%1.50B

7.35%1.47B

9.87%1.44B

67.80%1.41B

66.87%1.39B

67.58%1.37B

118.26%1.31B

--840.83M

--832.76M

--818.12M

6.23%600.94M

--565.68M

--171.44M

Retained earnings

-42.16%-874.97M

-35.57%-810.83M

-36.49%-762.39M

-47.40%-687.47M

-36.85%-615.46M

-45.61%-598.10M

-76.22%-558.57M

---466.39M

---449.75M

---410.74M

-126.35%-316.97M

---140.04M

--20.79M

Capital reserves

8.15%1.49B

7.38%1.46B

9.91%1.43B

68.41%1.40B

67.43%1.38B

68.16%1.36B

119.74%1.30B

--829.40M

--821.61M

--807.01M

6.33%590.77M

--555.63M

----

Gains losses not affecting retained earnings

-10.77%3.86M

-4.80%4.22M

7.30%4.79M

4.93%4.64M

-2.15%4.33M

0.27%4.43M

1.02%4.47M

--4.42M

0.00%4.42M

--4.42M

----

Total equity

-18.89%631.42M

-14.43%665.22M

-9.78%683.43M

92.17%728.07M

100.93%778.50M

88.77%777.36M

162.66%757.50M

--378.86M

--387.44M

--411.80M

-32.94%288.39M

--430.07M

--193.31M

Currency unit

--USD

Audit opinions

----

FAQs

Which balance sheet metrics matter most when analyzing NAMS stock?



Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

What is the difference between assets, liabilities, and shareholders' equity?



Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

What is the difference between current and non-current items?



Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

How Much Cash Does NewAmsterdam Pharma Company NV Have?



In its most recent quarterly, NewAmsterdam Pharma Company NV had 424.15M in cash and cash equivalents.

How Much Are NewAmsterdam Pharma Company NV's Total Liabilities?



NewAmsterdam Pharma Company NV reported 85.85M in total liabilities as of the latest reported quarter, including 85.79M in current liabilities and 66.00K in non-current liabilities.

What Are NewAmsterdam Pharma Company NV's Total Assets?



As of the latest reported quarter, NewAmsterdam Pharma Company NV's total assets were 769.28M, consisting of 675.70M in current assets and 93.58M in non-current assets.

How Much Shareholders' Equity Does NewAmsterdam Pharma Company NV Have?



NewAmsterdam Pharma Company NV reported 683.43M in total shareholders' equity as of the latest reported quarter.